SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001157523-12-002501
Filing Date
2012-05-03
Accepted
2012-05-03 16:35:14
Documents
2
Period of Report
2012-05-03
Filing Date Changed
2012-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NPS PHARMACEUTICALS, INC. 8-K a50263262.htm 8-K 16321
2 EXHIBIT 99.1 a50263262ex99_1.htm EX-99.1 81169
  Complete submission text file 0001157523-12-002501.txt   98595
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 12810230
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1